StabiLux Biosciences

Private

Ann Arbor, MichiganHealthcare & Life Scienceshttps://stabilux-biosciences.com/

Last Round

Grant

Oct 19, 2020

Total Funding Raised

$1.25M

Company Overview

StabiLux Biosciences is a biotechnology company that develops proprietary high-brightness fluorophores to improve reagents for flow cytometers used in biomedical research.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Biotech Equipment, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Hardware Sales

AI Layer

Non-AI

Keywords

flow cytometryfluorophoresfluorescent dyesbiomarker detectionnanoparticle technologybiotech reagentsflow cytometry reagentsboron nitride nanoparticlesimmunology researchdrug discoveryoncology researchfluorescent probescell analysiscustom formulationbiotech lab supplies

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

StabiLux Biosciences Comps

Public and private peers based on sector, stage, and business model.

StabiLux Biosciences comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

StabiLux Biosciences Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Grant	Oct 19, 2020
Accelerator	Sep 24, 2020
Grant	Jun 25, 2020
Grant	Nov 7, 2017
Seed	Sep 29, 2017
Grant	May 1, 2016

View all Funding Rounds

Key People

Founding team and executive leadership

Steve Tokarz

Chief Executive Officer

Executive Team

StabiLux Biosciences Investors

Notable investors and investment history

StabiLux Biosciences investors
Investor	Rounds
Cantilever Opportunity Fund, LP	SAFE
Ann Arbor SPARK	Grant, Accelerator
ID Ventures	Grant
Invest Michigan	Seed, Grant
National Science Foundation	Grant, Accelerator

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Sep 24, 2020
$50K round from Ann Arbor SPARK and NSF.

View all signals

StabiLux Biosciences Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

StabiLux Biosciences Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about StabiLux Biosciences's valuation, stock price, and market status.

Firmographic Details

HeadquartersAnn Arbor, Michigan

Employee Range10

Year Founded2014

Last FundingOct 19, 2020

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.